As a dedicated psychedelics GMP manufacturer, Psygen has harnessed more than 50 years of combined experience synthesizing psychedelics to provide a catalogue of APIs for clinicians, researchers, and drug developers.
A New Generation of Medicine
Psygen will build a psychedelic supply chain. We will synthesize GMP psychedelics in the world’s leading dedicated manufacturing facility to meet global demand and accelerate psychedelic research.
At Psygen our work is our purpose.
Our goal is to become the world’s most trusted source for pharmaceutical grade psychedelic APIs. The team at Psygen is inspired by a duty to provide these medicines and to ensure their transformative potential is better understood and accessible to the industry.
Psygen’s State-of-the-art facility
Psygen’s 17,000 sq. ft. facility will be GMP-compliant and enable large-scale synthesis of psychedelic compounds in a production area of 6,000 sq. ft.
Psygen has applied for a Health Canada dealer’s license which allows the manufacture, sale, import, export, and analysis of LSD, 2C-B, DMT, MDMA, psilocybin, and mescaline.
Psygen is the source.
We are one of world’s first manufacturer dedicated exclusively to the synthesis of GMP-compliant psychedelics.
Psygen is ready.
Our extensive experience in chemical synthesis means we are prepared to address the industrial-scale challenges that lie ahead.
Offers this sector an uninterrupted supply of APIs. Our systems are designed to meet or exceed global demand – and will constantly evolve as the sector expands.
Generates great loyalty. Today our goal is to create new, authentic, long-term relationships – allowing our customers to focus on growth, healing, and connection.
Psygen is trusted.
The burgeoning industry has faith in our chemistry and can rely on us to deliver. We are committed to excellence and reliability, improving access to psychedelic drugs for researchers and therapeutic applications.